In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Universal Medicare Pvt. Ltd.

Latest From Universal Medicare Pvt. Ltd.

Deal Watch: Seagen Ups Presence In HER2-Positive Cancer Field With RemeGen Deal

Lilly partners with Kumquat to discover small molecule IO drug. Kite, Appia Bio collaborate on allogeneic cell therapies. AstraZeneca and Regeneron pursue novel metabolic therapies targeting GPR75. Lexeo and Stelios merge to focus on gene therapies for rare cardiovascular indications.

Deals M & A

Asia Spotlight: Emerging Markets At Stake As Viehbacher Departs Sanofi?

As emerging markets represent 32% of Sanofi’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?

BioPharmaceutical North America

Emerging Markets At Stake As Viehbacher Departs Sanofi?

As emerging markets represent 32% of Sanofi’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?

BioPharmaceutical China

In Challenging Times, Sanofi’s Viehbacher Explores New Pricing Models In Emerging Markets

In a rare spotlight opportunity, Sanofi CEO Christopher Viehbacher shares his views on emerging markets during a visit to Mumbai.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register